Related content

Efficacy and safety over 26 weeks of an oral treatment strategy including sitagliptin compared with an injectable treatment strategy with liraglutide in patients with type 2 diabetes mellitus inadequately controlled on metformin: a randomised clinical trial

By Charbonnel B.   Steinberg H.   Eymard E.   Xu L.   Thakkar P.   Prabhu V.   Davies M.   Engel S.  

Diabetologia, Vol. 56, Iss. 7, 2013-07 ,pp. : 1503-1511

Springer Publishing Company

Access to resources Recommend Favorite

Spotlight on Rosiglitazone in the Management of Type 2 Diabetes Mellitus

By Wagstaff A.J.   Goa K.L.  

Treatments in Endocrinology, Vol. 1, Iss. 6, 2002-01 ,pp. : 411-414

Adis International

Access to resources Recommend Favorite

Treatment of Microalbuminuria in Patients with Type 2 Diabetes Mellitus

By Jerums G.   MacIsaac R.J.  

Treatments in Endocrinology, Vol. 1, Iss. 3, 2002-03 ,pp. : 163-173

Adis International

Access to resources Recommend Favorite

A deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus

By Iwasaki Hirohiko   Kajimura Masayoshi   Osawa Satoshi   Kanaoka Shigeru   Furuta Takahisa   Ikuma Mutsuhiro   Hishida Akira  

Journal of Gastroenterology, Vol. 41, Iss. 11, 2006-11 ,pp. : 1076-1087

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of uptitration of gliclazide with the addition of rosiglitazone to gliclazide in patients with type 2 diabetes inadequately controlled on half-maximal doses of a sulphonylurea

By Baksi A.   James R.   Zhou B.   Nolan J.  

Acta Diabetologica, Vol. 41, Iss. 2, 2004-06 ,pp. : 63-69

Springer Publishing Company

Access to resources Recommend Favorite